Literature DB >> 35107548

The 6-Minute Walk Test predicts long-term physical improvement among intensive care unit survivors: a prospective cohort study.

Regis Goulart Rosa1, Camila Dietrich2, Enio Luiz Tschiedel do Valle1, Denise Souza1, Luciana Tagliari1, Mariana Mattioni1, Túlio Frederico Tonietto1, Rosa da Rosa1, Mirceli Goulart Barbosa2, Gisele Agustini Lovatel2, Pedro Dal Lago2, Eubrando Silvestre Oliveira1, Daniel Sganzerla1, Juliana M S Andrade3, Paula Berto4, Paulo Ricardo Cardoso4, Evelin Carneiro Sanchez1, Maicon Falavigna1, Juçara G Maccari1, Gabriela Rech1, Caroline Robinson1, Daniel Schneider1, Patrícia de Leon1, Lívia Biason1, Cassiano Teixeira1,2,4.   

Abstract

OBJECTIVE: To evaluate the ability of the 6-Minute Walk Test to predict long-term physical functional status improvement among intensive care unit survivors.
METHODS: Thirty-two intensive care unit survivors were prospectively evaluated from February 2017 to August 2018 in a post-intensive care unit outpatient clinic in Brazil. Individuals with intensive care unit stays > 72 hours (emergency admissions) or > 120 hours (elective admissions) attending the post-intensive care unit clinic four months after intensive care unit discharge were consecutively enrolled. The association between the 6-Minute Walk Test distance at baseline and physical functional status was assessed over 8 months using the Barthel Index.
RESULTS: The mean 6-Minute Walk Test distance was significantly lower in intensive care unit survivors than in the general population (405m versus 557m; p < 0.001). Age (β = -4.0; p < 0.001) and muscle weakness (β = -99.7; p = 0.02) were associated with the 6-Minute Walk Test distance. A 6-Minute Walk Test distance was associated with improvement in physical functional status over the 8-month follow-up (odds ratio for each 10m of 1.07; 95%CI 1.01 - 1.16; p = 0.03). The area under the Receiver Operating Characteristic curve for the 6-Minute Walk Test prediction of physical functional status improvement was 0.72 (95%CI 0.53 - 0.88).
CONCLUSION: The 6-Minute Walk Test performed 4 months after intensive care unit discharge predicted long-term physical functional status among intensive care unit survivors with moderate accuracy.

Entities:  

Mesh:

Year:  2021        PMID: 35107548      PMCID: PMC8555392          DOI: 10.5935/0103-507X.20210056

Source DB:  PubMed          Journal:  Rev Bras Ter Intensiva        ISSN: 0103-507X


INTRODUCTION

The long-term physical, cognitive, and mental health disabilities that often affect survivors of critical illness are associated with decreased quality of life for subjects and their families.( Additionally, physical impairment after discharge from the intensive care unit (ICU) complicates access to rehabilitation and return to work or studies and has been associated with death.( The 6-Minute Walk Test (6MWT) is a standardized measure of functional exercise capacity( that has been proposed as a prognostic factor for subjects with chronic disorders such as chronic obstructive pulmonary disease (COPD), heart failure, and pulmonary arterial hypertension.( Among COPD subjects, for example, the distance covered during the 6MWT has been associated with hospitalizations and survival.( The 6MWT is easy to perform, well tolerated, safe, and more reflective of activities for daily living than other walking tests.( Moreover, the 6MWT is frequently used in cohorts of ICU survivors to assess recovery of exercise capacity;( however, the literature evaluating the 6MWT as a predictor of long-term physical improvement in this population is scarce. Accordingly, the present study aimed to evaluate the 6MWT as a predictor of long-term physical improvement in general ICU survivors attending a post-ICU outpatient clinic.

METHODS

This prospective cohort study was conducted with consecutive ICU survivors attending a post-ICU outpatient referral clinic that provides follow-up care to subjects from four tertiary hospitals in Porto Alegre (RS), Brazil. The 6MWT was performed at the clinic 4 months after discharge from the ICU as part of the baseline physical assessment of these subjects. Subjects were followed up for eight months using structured telephone interviews. The study was conducted in accordance with good clinical practice and approved by the institutional review boards of all participating centers. Consent for participation was obtained from all study subjects or their proxies. The inclusion criteria were age ≥ 18 years, ICU stay ≥ 72 hours in cases of emergency medical or surgical admissions or ≥ 120 hours in cases of elective surgical admissions. The exclusion criteria were the presence of any contraindications or limitations to perform the 6MWT (i.e., inability to walk, unstable cardiac disease, unstable respiratory disease, severe cognitive impairment, or any medical contraindication).

Definitions

Characteristics related to ICU stay (ICU admission type, risk of death at ICU admission, diagnosis of sepsis, organ dysfunction during ICU stay, and length of ICU stay) were obtained retrospectively through review of medical records by site investigators of each of the four hospitals referring subjects to the outpatient clinic. The risk of death at ICU admission was calculated according to the Acute Physiology and Chronic Health Evaluation II (APACHE II)( or the Simplified Acute Physiology Score 3 (SAPS 3).( Sepsis was defined according to sepsis 2 criteria.( Organ dysfunction was defined as the presence of any of the following conditions during the ICU stay: need for invasive mechanical ventilation, vasopressors, renal replacement therapy (except for subjects under chronic dialysis treatment), parenteral nutrition, blood or blood product transfusion, and delirium (measured according the Confusion Assessment Method for the ICU).( Variables related to the patient’s health status at the post-ICU outpatient evaluation - during the first 7 days after ICU discharge (age, educational attainment, comorbidities, physical functional status, muscle strength, frailty, cognitive status, resilience and symptoms of anxiety, depression, and posttraumatic stress disorder - PTSD) were evaluated by trained investigators during face-to-face assessments with validated tools. Comorbidities were assessed using the Charlson Comorbidity Index (CCI; scores range from zero to 33, with higher scores indicating greater comorbidity).( The CCI score was dichotomized into low (zero or one) or high comorbidity (≥ 2). Physical functional status was assessed using the Barthel Index (BI; scores range from zero to one hundred, with higher scores indicating better functional status).( Subjects were classified as independent (BI > 95), mildly dependent (BI > 75 to 95), moderately dependent (BI > 50 to 75), or severely dependent (BI ≤ 50). Muscle strength was assessed using the Medical Research Council scale (MRC; scores range from zero to 60, with higher scores indicating greater strength).( Muscle weakness was defined as an MRC score < 48. Frailty was assessed using the modified frailty index (MFI, scores range from zero to 11, with higher scores indicating higher frailty).( Cognition was assessed using the Mini Mental State Examination (MMSE, scores range from zero to 30, with higher scores indicating better cognition).( Resilience was assessed using the Connor-Davidson resilience scale (scores range from zero to one hundred, with higher scores reflecting higher resilience).( Anxiety and depression symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS, scores on anxiety and depression scales range from zero to 21, with higher scores indicating worse symptoms).( A cutoff > 7 for the HADS anxiety and depression subscales was used to define possible anxiety and depression. Symptoms of PTSD were assessed using the Impact Event Scale-6 (IES-6, scores range from zero to 24, with higher scores indicating worse symptoms);( a cut off > 10 was used to define possible PTSD.

6-Minute Walk Test

The 6MWT was supervised by ratters not associated with care in accordance with international guidelines( as part of the baseline post-ICU follow-up assessment (4 months after ICU discharge). Subjects were instructed to walk along a 30-meter corridor for 6 minutes and received encouragement during the test.

Outcome

The main outcome was the variation in physical functional status based on the BI( over the eight-month follow-up period (BI score at 8 months minus BI score at baseline). Subjects with BI variation ≥ +5 points were classified as having improved their physical functional status. Subjects who died during the follow-up were classified as not having improved their physical functional status. Investigators not associated with care and blinded to baseline variables performed both BI evaluations using structured telephone interviews.(

Statistical analysis

Continuous variables are expressed as the median and interquartile range (IQR). Categorical variables are expressed as counts and percentages. The paired sample t-test or the Wilcoxon sign rank-test were used to compare 6MWT distances completed by study participants with expected values for heathy individuals (adjusted by gender, age, and body mass index - BMI),( COPD subjects,( and heart failure subjects.( Stepwise multivariate linear regression was used to assess factors associated with the distance walked in the 6MWT. All variables with a p < 0.20 in the univariate analysis were included in the multivariate model using the forward selection procedure with stopping rules based on a cutoff of 0.05 for p-values. The association between the distance walked in the 6MWT and improvement in physical functional status over time was assessed through logistic regression. The accuracy of the 6MWT in predicting improvement in physical functional status was evaluated using actual and estimated values for the area under the Receiver Operating Characteristic curve (AUROC). An AUROC greater than 0.8 indicated good prediction performance, whereas an AUROC between 0.6 - 0.8 and lower than 0.6 indicated moderate and poor prediction performance, respectively. The significance level adopted was 5%. All analyses were performed with R software (R Development Core Team).(

RESULTS

Study population characteristics

From February 2017 to August 2018, 311 subjects were screened (Figure 1). Of these, 64 were assessed for eligibility. Eventually, 32 subjects were able to perform the 6MWT and were enrolled in the study. Of these subjects, 30 completed the protocol (one patient died, and one patient was lost to follow-up before the eight-month evaluation). Table 1 summarizes the characteristics of the study population. The median age was 58.5 years (IQR 37.5 - 67.5), and 56.2% of participants were women. Median education attainment was 11.0 years (IQR 9.8 - 16.0). Regarding critical illness, 71.9% of subjects were admitted to the ICU due to medical reasons and 22.1% due to surgery. The median risk of death at ICU admission was 18.6% (IQR 11.3 - 35.7). Sepsis or septic shock was present in 40.6% of subjects at the moment of ICU admission. The median number of organ dysfunctions during the ICU stay was 1.0 (IQR 0 - 2.3), and the median length of ICU stay was 7 days (IQR 4.0 - 11.0). At the moment of post-ICU outpatient assessment, 34.3% were functionally independent, 31.2% had high comorbidity, 77.4% had muscle weakness, 32.3% had possible anxiety, 16.1% had possible depression, and 22.6% had possible PTSD. The median MFI, MMSE, and Connor-Davidson Resilience Scale scores were 2.0 (IQR 0 - 3), 26.0 (IQR 23.0 - 29.0), and 81.0 (IQR 70.0 - 87.0), respectively.
Figure 1

Participant flow diagram.

ICU - intensive care unit; 6MWT - 6-Minute Walk Test.

Table 1

Patient characteristics

CharacteristicsValues
Sociodemographic 
  Age (years)58.6 (37.5 - 67.5)
  Female sex18/32 (56.2)
  Education attainment (years)11.0 (9.8 - 16.0)
    Higher education11/32 (34.4)
Critical illness 
  ICU admission type (%) 
    Medical, emergency23/32 (71.9)
    Surgical, elective5/32 (15.6)
    Surgical, emergency4/32 (12.5)
  Risk of death at ICU admission* %18.6 (14.2 - 33.7)
  Severe sepsis or septic shock at ICU admission13/32 (40.6)
  Number of organ dysfunctions during ICU stay1.0 (0 - 2.3)
  Length of ICU stay7.0 (4.0 - 11.0)
Health status at the moment of post-ICU outpatient assessment 
  Physical functional status 
    Independent11/32 (34.3)
    Mildly dependent17/32 (53.1)
    Moderately dependent4/32 (12.5)
    Severely dependent0
  Charlson Comorbidity Index0 (0 - 2)
    High comorbidity†10/32 (31.2)
  MRC strength score58 (50.0 - 60.0)
    Muscle weakness‡24/32 (77.4)
  Modified frailty index2.0 (0 - 3.0)
  MMSE score26.0 (23.0 - 29.0)
  Connor-Davidson resilience score81.0 (70.0 - 87.0)
  HADS anxiety score6.0 (3.5 - 9.5)
    Possible anxiety§10/31 (32.3)
  HADS depression score4.0 (2.5 - 6.5)
    Possible depression¶5/31 (16.1)
  IES-6 score5.0 (2.0 - 8.5)
    Possible PTSD||7/31 (22.6)

ICU - intensive care unit; MRC - Medical Research Council; MMSE - Mini Mental State Examination; HADS - Hospital Anxiety and Depression Scale; IES-6 - Impact Event Scale-6; PTSD - posttraumatic stress disorder. * According to the Simplified Acute Physiology Score 3 or the Acute Physiology and Chronic Health Evaluation II score; † Charlson Comorbidity Index ≥ 2; ‡ Medical Research Council score < 48; § Hospital Anxiety and Depression Scale anxiety score > 7; ¶ Hospital Anxiety and Depression Scale depression score > 7; || Impact Event Scale-6 score >10. Results expressed as median (interquartile range) or n/total n (%).

Participant flow diagram. ICU - intensive care unit; 6MWT - 6-Minute Walk Test. Patient characteristics ICU - intensive care unit; MRC - Medical Research Council; MMSE - Mini Mental State Examination; HADS - Hospital Anxiety and Depression Scale; IES-6 - Impact Event Scale-6; PTSD - posttraumatic stress disorder. * According to the Simplified Acute Physiology Score 3 or the Acute Physiology and Chronic Health Evaluation II score; † Charlson Comorbidity Index ≥ 2; ‡ Medical Research Council score < 48; § Hospital Anxiety and Depression Scale anxiety score > 7; ¶ Hospital Anxiety and Depression Scale depression score > 7; || Impact Event Scale-6 score >10. Results expressed as median (interquartile range) or n/total n (%).

Results of the 6-Minute Walk Test

Data regarding the distance walked in the 6MWT and the comparison across distinct populations are shown in figure 2. The mean distance walked was 405m (standard deviation of 135.9m). The mean 6MWT distance of ICU survivors was significantly lower than the predicted values for a healthy population considering sex, age, and BMI (405m versus 557m; p < 0.001). Intensive care unit subjects also walked lower distances than COPD subjects classified as Global Initiative for Obstructive Lung Disease (GOLD) stage ≥ II (median 455m versus 477m; p < 0.001) and heart failure subjects classified as New York Heart Association (NYHA) class II (mean 405m versus 456m; p = 0.02).
Figure 2

Distance walked in the 6-Minute Walk Test by intensive care unit survivors. (A) Summary of the distance walked in the 6-Minute Walk Test by intensive care unit survivors (box plot) compared with healthy individuals (blue dashed line), chronic obstructive pulmonary disease patients (green dashed line), and heart failure patients (red dashed line). (B) The sorted observations of the 6-Minute Walk Test distance among study subjects.

* According to Britto et al.;( † according to Rodrigues et al.;( ‡ according to Oliveira et al.(

COPD - chronic obstructive pulmonary disease; GOLD - Global Initiative for Chronic Obstructive Lung Disease; NYHA - New York Heart Association.

Distance walked in the 6-Minute Walk Test by intensive care unit survivors. (A) Summary of the distance walked in the 6-Minute Walk Test by intensive care unit survivors (box plot) compared with healthy individuals (blue dashed line), chronic obstructive pulmonary disease patients (green dashed line), and heart failure patients (red dashed line). (B) The sorted observations of the 6-Minute Walk Test distance among study subjects. * According to Britto et al.;( † according to Rodrigues et al.;( ‡ according to Oliveira et al.( COPD - chronic obstructive pulmonary disease; GOLD - Global Initiative for Chronic Obstructive Lung Disease; NYHA - New York Heart Association.

Factors associated with 6-Minute Walk Test distance

Univariate and multivariate analyses of factors associated with distance walked in the 6MWT are shown in table 2. Upon multivariate analysis, older age (b-4.0; p < 0.001) and muscle weakness (b-99.7; p = 0.02) were independently associated with lower 6MWT distances.
Table 2

Factors associated with the distance covered in the six-minute walk test

VariablesUnivariate analysisMultivariate analysis*
ß (95%CI)p valueß (95%CI)p value
Sociodemographic    
  Age (years)-4.7 (-6.91 - -2.64)< 0.001-4.0 (-6.1 - -1.9)<0.001
  Female sex-37.0 (-136.6 - 62.5)0.45--
  Education attainment (years)7.5 (-2.1 - 17.2)0.12--
    Higher education24.2 (-80.4 - 128.8)0.64--
Critical illness    
  ICU admission type (%)    
    Medical, emergencyReference---
    Surgical, elective-6.8 (-146.1 - 132.5)0.92--
    Surgical, emergency73.4 (-79.5 - 226.4)0.33--
  Risk of death at ICU admission per 1% increase0.4 (-2.6 - 3.5)0.77--
  Sepsis or septic shock at ICU admission-35.2 (-135.9 - 65.4)0.48--
  No. of organ dysfunctions during ICU stay18.1 (-17.0 - 53.3)0.30--
  Length of ICU stay (days)-2.31 (-7.9 - 3.2)0.40--
Post-ICU clinic assessment    
  Physical functional status    
    IndependentReference---
    Mildly dependent115.0 (-31.5 -261.5)0.13--
    Moderately dependent191.5 (38.5 - 344.6)0.01--
  Charlson comorbidity index per point-17.0 (-48.0 - 13.9)0.26--
    High comorbidity-66.0 (-170.8 - 38.6)0.20--
  MRC strength score per point5.6 (1.19 - 10.1)0.01--
    Muscle weakness-133.8 (-240.5 - -27.1)0.01-99.7 (-188.5 - -10.9)0.02
  Modified frailty index per point-26.2 (-53.4 - 0.9)0.05--
  MMSE score per point14.6 (5.5 - 23.6)0.002--
  Connor-Davidson resilience score per point0.61 (-3.1 - 4.3)0.74--
  HADS anxiety score per point2.2 (-8.1 - 12.6)0.66--
    Possible anxiety-2.3 (-101.3 - 96.5)0.96--
  HADS depression score per point5.2 (-6.2 - 16.6)0.36--
    Possible depression19.5 (-105.9 - 145.0)0.75--
  IES-6 score per point3.3 (-6.1 - 12.8)0.47--
    Possible PTSD59.7 (-48.5 - 167.9)0.26--

95% CI - 95% confidence interval; ICU - intensive care unit; MRC - Medical Research Council; MMSE - Mini Mental State Examination; HADS - Hospital Anxiety and Depression Scale; IES-6 - Impact Event Scale-6; PTSD - posttraumatic stress disorder. * The following variables were entered in the multivariate model: education attainment, physical functional status, muscle weakness, modified frailty index and Mini Mental State Examination score. We did not include the Medical Research Council strength score due to collinearity between this variable and muscle weakness. Only variables with a p value < 0.05 in the multivariate model are shown.

Factors associated with the distance covered in the six-minute walk test 95% CI - 95% confidence interval; ICU - intensive care unit; MRC - Medical Research Council; MMSE - Mini Mental State Examination; HADS - Hospital Anxiety and Depression Scale; IES-6 - Impact Event Scale-6; PTSD - posttraumatic stress disorder. * The following variables were entered in the multivariate model: education attainment, physical functional status, muscle weakness, modified frailty index and Mini Mental State Examination score. We did not include the Medical Research Council strength score due to collinearity between this variable and muscle weakness. Only variables with a p value < 0.05 in the multivariate model are shown.

Association between 6-Minute Walk Test distance and improvement in physical functional status

Eighteen subjects (58.0%) had their physical functional status improved during the follow-up period. The mean 6MWT distance covered by subjects with improved physical functional status was significantly higher than that of subjects whose functional status did not improve (451m versus 340m; p = 0.03). The odds ratio of each additional 10m of walking in the 6MWT for improvement of physical functional status was 1.07 (95% confidence interval - 95%CI 1.01 - 1.16). The analysis of the AUROC for the prediction of improvement in physical functional status showed moderate predictive accuracy for the 6MWT (AUROC 0.72; 95%CI 0.53 - 0.88) (Figure 3).
Figure 3

Actual and predicted area under the Receiver Operating Characteristic curve for the ability of the 6-Minute Walk Test to predict improvement in physical functional status over time. (A) The actual area under the Receiver Operating Characteristic (95% confidence interval). (B) The predicted area under the Receiver Operating Characteristic for the ability of the 6-Minute Walk Test to predict improvement in physical functional status over time.

AUROC - area under the Receiver Operating Characteristic curve.

Actual and predicted area under the Receiver Operating Characteristic curve for the ability of the 6-Minute Walk Test to predict improvement in physical functional status over time. (A) The actual area under the Receiver Operating Characteristic (95% confidence interval). (B) The predicted area under the Receiver Operating Characteristic for the ability of the 6-Minute Walk Test to predict improvement in physical functional status over time. AUROC - area under the Receiver Operating Characteristic curve.

DISCUSSION

In this prospective cohort study involving ICU survivors attending a post-ICU outpatient clinic four months after ICU discharge, the 6MWT was able to predict long-term physical improvement with moderate accuracy. Additionally, we found that older age and muscle weakness were associated with lower distances covered in the 6MWT four months after ICU discharge. Nearly two-thirds of ICU survivors are affected by physical dysfunction, which is typically long lasting and associated with a reduced quality of life.( Common causes of physical disability among ICU survivors include loss of muscle mass, joint dysfunction, chronic pain, and reduced tolerance to exercise, which are potentially treatable conditions. Our findings are consistent with previous studies demonstrating the low exercise capacity of ICU survivors as measured by the 6MWT.( Notably, in our study, the mean distance walked in the 6MWT by ICU survivors was significantly lower than that covered by healthy individuals and subjects with chronic diseases that impact quality of life (i.e., COPD and heart failure).( In ICU survivors, the 6MWT is usually employed as a tool to determine physical disability rather than as a prognostic marker of physical improvement over time.( In our study, the distance walked in the 6MWT showed promising results as a predictor of improvement in physical function over an eight-month period. Additionally, we found that older age and muscle weakness were associated with lower distances covered in the 6MWT four months after ICU discharge. Age is associated with frailty, comorbidities, and muscle function impairment-the main factors related to reduced walking ability. These results have clinical applicability, given the increasing interest in assessing physical disability in post-ICU care( and the need to improve long-term outcomes of survivors of critical illness.( The efficacy of the current post-ICU follow-up models for the improvement of physical disability has been questioned,( and the use of personalized rehabilitation strategies based on individual risk factors for long-term physical disability has been proposed as a promising approach for ICU survivors.( In this sense, the use of prognostic tools may contribute to a more efficient allocation of resources aimed at rehabilitating subjects who would benefit the most from this kind of intervention. The strengths of our study include its prospective design, the start of follow-up after ICU discharge, during routine outpatient rehabilitation care, and the focus on the predictive accuracy of the 6MWT for long-term physical functional status improvement. Nevertheless, some limitations must be considered. First, our sample was small and, therefore, may not be representative of all ICU survivors, given the peculiarities of ICU subjects in specific contexts, such as trauma, surgery, and sepsis. Second, our study is susceptible to biases inherent to observational studies (i.e., confounding and selection and assessment bias). However, the possibility of systematic errors was minimized by adequate measurement of variables and outcomes with previously defined objective criteria, the use of standardized data collection, and follow-up performed by a research team that was not involved in patient care.

CONCLUSION

The distance covered in the 6-Minute Walk Test appears useful for assessing the long-term physical functional status recovery among intensive care unit survivors.
  42 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU).

Authors:  E W Ely; R Margolin; J Francis; L May; B Truman; R Dittus; T Speroff; S Gautam; G R Bernard; S K Inouye
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

3.  Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome.

Authors:  R P Kleyweg; F G van der Meché; P I Schmitz
Journal:  Muscle Nerve       Date:  1991-11       Impact factor: 3.217

4.  Functional Status in ICU Survivors and Out of Hospital Outcomes: A Cohort Study.

Authors:  Jessica E Rydingsward; Clare M Horkan; Kris M Mogensen; Sadeq A Quraishi; Karin Amrein; Kenneth B Christopher
Journal:  Crit Care Med       Date:  2016-05       Impact factor: 7.598

Review 5.  Enhancing Recovery From Sepsis: A Review.

Authors:  Hallie C Prescott; Derek C Angus
Journal:  JAMA       Date:  2018-01-02       Impact factor: 56.272

6.  Physical function impairment in survivors of critical illness in an ICU Recovery Clinic.

Authors:  Rita N Bakhru; James F Davidson; Rebecca E Bookstaver; Michael T Kenes; Kristin G Welborn; Peter E Morris; D Clark Files
Journal:  J Crit Care       Date:  2018-02-03       Impact factor: 3.425

7.  Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group.

Authors:  M Ferrer; J Alonso; J Morera; R M Marrades; A Khalaf; M C Aguar; V Plaza; L Prieto; J M Antó
Journal:  Ann Intern Med       Date:  1997-12-15       Impact factor: 25.391

Review 8.  An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease.

Authors:  Anne E Holland; Martijn A Spruit; Thierry Troosters; Milo A Puhan; Véronique Pepin; Didier Saey; Meredith C McCormack; Brian W Carlin; Frank C Sciurba; Fabio Pitta; Jack Wanger; Neil MacIntyre; David A Kaminsky; Bruce H Culver; Susan M Revill; Nidia A Hernandes; Vasileios Andrianopoulos; Carlos Augusto Camillo; Katy E Mitchell; Annemarie L Lee; Catherine J Hill; Sally J Singh
Journal:  Eur Respir J       Date:  2014-10-30       Impact factor: 16.671

9.  Brief measure of posttraumatic stress reactions: impact of Event Scale-6.

Authors:  Siri Thoresen; Kristian Tambs; Ajmal Hussain; Trond Heir; Venke A Johansen; Jonathan I Bisson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-05-29       Impact factor: 4.328

10.  Cluster analysis identifying patients with COPD at high risk of 2-year all-cause mortality.

Authors:  Antenor Rodrigues; Carlos Augusto Camillo; Karina Couto Furlanetto; Thais Paes; Andrea Akemi Morita; Thamyres Spositon; Leila Donaria; Marcos Ribeiro; Vanessa Suziane Probst; Nidia Aparecida Hernandes; Fabio Pitta
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.